Delivery Order SPE2DB25D3003-SPE2DB25FPWXC
Award Date 8/5/25
Potential Completion Date 8/6/25
Potential Value $1.6K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $1,802.00 to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick auto-injectors on July 24, 2025, with an ultimate completion date of July 25, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and specifies performance at the awardee's corporate office location in Conshohocken, Pennsylvania. Repatha is a prescription medication used to lower cholesterol levels in patients with...
- The Defense Logistics Agency awarded a delivery order valued at $17,390.89 to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors, with performance in Conshohocken, Pennsylvania and completion targeted for July 31, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors valued at $7,567.40 on August 26, 2025, with an ultimate completion date of August 27, 2025. This is a firm fixed price, competitively awarded delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a prime vendor for federal pharmaceutical procurement and will fulfill this order from its...
- The Defense Logistics Agency awarded a delivery order valued at $6,890.32 to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors, with an ultimate completion date of April 30, 2025. This non-set-aside, firm fixed-price contract was competitively awarded on April 29, 2025, and will be performed at the vendor's corporate office in Conshohocken, Pennsylvania. Repatha is a PCSK9 inhibitor indicated for the treatment of high cholesterol and cardiovascular disease prevention,...
- The Defense Logistics Agency awarded a delivery order valued at $17,139.13 to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick auto-injectors. The contract, awarded on September 9, 2025, with completion targeted for September 10, 2025, operates under a firm fixed-price delivery order structure with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as the prime contractor for this order. Repatha...
- The Defense Logistics Agency awarded a delivery order valued at $1,041.42 to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors, with a completion date of July 23, 2025. This non-competitive, firm fixed-price delivery order was issued on July 22, 2025, and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. Repatha is a prescription medication used to treat high cholesterol and reduce the risk of cardiovascular disease. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Repatha 140 mg/ml SureClick auto-injectors, valued at $18,082.21. This is a firm fixed-price delivery order with no set-aside designation, reflecting competitive award practices. The contract is set to be completed by September 10, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Repatha is a PCSK9 inhibitor used...
- The Defense Logistics Agency awarded a delivery order valued at $42,622.35 to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injector pens, with an ultimate completion date of September 5, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a standalone procurement from the vendor's location in Conshohocken, Pennsylvania. Repatha is a prescription medication used for cholesterol management and cardiovascular...
- The Defense Logistics Agency awarded a delivery order valued at $9,864.24 to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick auto-injector pens, with a completion deadline of August 20, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Repatha is a prescription medication used to treat high cholesterol, and this delivery order represents a routine...
- The Defense Logistics Agency awarded a delivery order valued at $5,390.03 to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors. This competitive award, issued on June 2, 2025, with an ultimate completion date of June 3, 2025, represents a firm fixed-price transaction with no set-aside designation. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Repatha is a PCSK9 inhibitor used to treat high cholesterol and...